Hardback : £88.55
Fundamental Concepts for New Clinical Trialists describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks.
The first section of the book provides background information about clinical trials. It defines and compares clinical trials to other types of research studies and discusses clinical trial phases, registration, the protocol document, ethical issues, product development, and regulatory processes. It also includes a special chapter outlining the valuable attributes that statisticians can develop to maximize their contributions to a clinical trial.
The second section examines scientific issues faced in each progressive step of a clinical trial. It covers issues in trial design, such as randomization, blinding, control-group selection, endpoint selection, superiority versus noninferiority, and parallel group versus crossover designs; data monitoring; analyses of efficacy, safety, and benefit-risk; and the reporting/publication of clinical trial results.
As clinical trials remain the gold standard research studies for evaluating the effects of a medical intervention, newcomers to the field must have a fundamental understanding of the concepts to tackle real-world issues in all stages of trials. Drawing on their experiences in academia and industry, the authors provide a foundation for understanding the fundamental concepts necessary for working in clinical trials.
Show moreFundamental Concepts for New Clinical Trialists describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks.
The first section of the book provides background information about clinical trials. It defines and compares clinical trials to other types of research studies and discusses clinical trial phases, registration, the protocol document, ethical issues, product development, and regulatory processes. It also includes a special chapter outlining the valuable attributes that statisticians can develop to maximize their contributions to a clinical trial.
The second section examines scientific issues faced in each progressive step of a clinical trial. It covers issues in trial design, such as randomization, blinding, control-group selection, endpoint selection, superiority versus noninferiority, and parallel group versus crossover designs; data monitoring; analyses of efficacy, safety, and benefit-risk; and the reporting/publication of clinical trial results.
As clinical trials remain the gold standard research studies for evaluating the effects of a medical intervention, newcomers to the field must have a fundamental understanding of the concepts to tackle real-world issues in all stages of trials. Drawing on their experiences in academia and industry, the authors provide a foundation for understanding the fundamental concepts necessary for working in clinical trials.
Show moreBackground: Clinical Trials. Product Development Process. Regulatory Review Organizations. Clinical Trial Statisticians. Scientific and Practical Issues: General Considerations in Clinical Trial Design. Clinical Trial Designs. Interim Data Monitoring. Analysis Considerations. Analysis of Safety, Benefit:Risk, and Quality of Life. Publishing Trial Results. Appendix. Index.
Dr. Scott Evans teaches clinical trials at Harvard University, where he is the director of the Statistical and Data Management Center for the Antibacterial Resistance Leadership Group, an NIH-funded clinical trials network. He serves on a U.S. FDA Advisory Committee and several data monitoring committees for industry and NIH-sponsored clinical trials. He has been a recipient of the Mosteller Statistician of the Year Award and is a fellow of the American Statistical Association. Dr. Evans is a visiting professor at the Department of Medical Statistics at Osaka University and serves as the executive editor for CHANCE and the editor-in-chief of Statistical Communications in Infectious Diseases.
Dr. Naitee Ting has close to 30 years of experience in the pharmaceutical industry and currently works at Boehringer Ingelheim. He has also taught courses on clinical trials in the Department of Statistics at the University of Connecticut, University of Rhode Island, and Department of Biostatistics at Columbia University. He is a fellow of the American Statistical Association.
"The book focuses on important concepts and promotes ‘thinking
clinical trials’, and it is very readable. This book targets both
statisticians and non-statisticians and wishes to facilitate better
communication between them. I found that some chapters are
especially useful for statisticians involved in clinical trials. .
. Dr Evans uses this book as part of his ‘Principles of Clinical
Trials’ course at the Harvard School of Public Health. Overall, it
is an exciting book!"
~International Statistical Review"Statisticians learn the easy part
of designing and analyzing clinical trials in class, but we usually
learn the hard parts by our post-graduate failures. This book
offers a course outline and valuable set of instructions to
describe how to avoid many lessons we might otherwise have to learn
the hard way."
~The International Biometric Society
"The book focuses on important concepts and promotes ‘thinking
clinical trials’, and it is very readable. This book targets both
statisticians and non-statisticians and wishes to facilitate better
communication between them. I found that some chapters are
especially useful for statisticians involved in clinical trials. .
. Dr Evans uses this book as part of his ‘Principles of Clinical
Trials’ course at the Harvard School of Public Health. Overall, it
is an exciting book!"
~International Statistical Review"Statisticians learn the easy part
of designing and analyzing clinical trials in class, but we usually
learn the hard parts by our post-graduate failures. This book
offers a course outline and valuable set of instructions to
describe how to avoid many lessons we might otherwise have to learn
the hard way." ~The International Biometric Society
|
Ask a Question About this Product More... |
|
